Nukkleus (NASDAQ:DFNS) Issues Quarterly Earnings Results, Beats Expectations By $1.01 EPS

Nukkleus (NASDAQ:DFNS) issued its quarterly earnings data on Tuesday. The company reported ($2.10) EPS for the quarter, beating analysts’ consensus estimates of ($3.11) by $1.01, Zacks reports. The firm had revenue of $4.00 million during the quarter, compared to analyst estimates of $4.50 million.

Nukkleus Trading Down 4.4%

Shares of NASDAQ DFNS opened at $26.01 on Thursday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.21 and a current ratio of 0.25. Nukkleus has a 52-week low of $3.70 and a 52-week high of $1,948.75. The firm has a 50 day moving average price of $25.30 and a two-hundred day moving average price of $93.07. The stock has a market cap of $26.27 million, a P/E ratio of -0.07 and a beta of -5.80.

Hedge Funds Weigh In On Nukkleus

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Geode Capital Management LLC raised its stake in Nukkleus by 193.7% during the fourth quarter. Geode Capital Management LLC now owns 124,714 shares of the company’s stock worth $503,000 after buying an additional 82,252 shares during the last quarter. UBS Group AG boosted its position in shares of Nukkleus by 23.3% during the 3rd quarter. UBS Group AG now owns 80,512 shares of the company’s stock valued at $564,000 after purchasing an additional 15,223 shares in the last quarter. LPL Financial LLC acquired a new stake in Nukkleus during the fourth quarter worth approximately $120,000. Engineers Gate Manager LP acquired a new position in Nukkleus in the fourth quarter valued at approximately $96,000. Finally, State Street Corp boosted its holdings in shares of Nukkleus by 70.7% during the 4th quarter. State Street Corp now owns 17,863 shares of the company’s stock worth $72,000 after buying an additional 7,400 shares in the last quarter. 12.47% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Weiss Ratings lowered shares of Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research report on Monday, July 20th. Wall Street Zen lowered shares of Nukkleus from a “sell” rating to a “strong sell” rating in a report on Saturday, August 15th. Finally, Noble Financial upgraded shares of Nukkleus to a “strong-buy” rating in a research report on Monday, June 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy”.

Nukkleus Company Profile

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.